Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis

Rheumazentrum Ruhrgebiet, St. Josefs-Krankenhaus, Herne, Germany.
Clinical and experimental rheumatology (Impact Factor: 2.72). 01/2009; 27(4 Suppl 55):S108-11.
Source: PubMed


In this review the influence of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) on a wide range of health-related quality of life (HRQoL) domains will be described. The domains most frequently studied are pain, functional disability, fatigue and mental problems. In addition, age and socio-economic aspects such as employment and economic status as well as education affect patient-reported HRQoL.Although many studies have assessed the impact on HRQoL of a single disease state, either RA or AS, few studies have focused on a direct comparison between those both diagnostic groups. In general, patients with RA and AS report significant decrements in HRQoL in comparison with the general population. It has been shown that the magnitude of the impairment is similar among both patients group.

19 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim and objectives: To point out the importance of complex treatment in patients suffering from secondary osteoporosis due to seronegative spondyloarthropathies. Material and methods: During a one year period we studied 128 patients suffering from secondary osteoporosis due to seronegative spondyloarthropathies divided into two homogenous groups. Group 1 followed medical treatment of the primary rheumatic disease and anti-osteoporotic therapy, while group 2 followed in addition a home-adapted kinetotherapy programme. Each patient was assessed 7 times (complex clinical examination, laboratory tests for inflammation, disease activity score, functional score and quality of life scale). Results: We noticed an increased BMD, normalisation of inflammation tests at 12 weeks, no progression of radiological aspects and a better quality of life in group 2 patients. Conclusions: Medical therapy of seronegative spondyloarthropathies including anti-osteoporotic treatment combined with an individualized home-adapted programme improves quality of life and increases BMD.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Whether physical functioning in patients with rheumatoid arthritis (RA) differs from that in patients with ankylosing spondylitis (AS) is presently uncertain. Such a comparison poses challenges, not only because the two diseases differ in the domains of functioning affected, but also because of the different instruments used to measure functional limitations. Limiting our analysis to studies using similar self-report questionnaires, we examined published observational studies of unselected cohorts of patients with RA and patients with AS to compare and contrast the severity of functional limitations. Available studies from a few direct comparisons, and mostly indirect comparisons, suggested that patients with RA are generally more severely limited in physical functioning throughout the disease course than patients with AS. Since most studies did not adjust adequately for potentially important confounders, such as age, gender, comorbidity, and disease duration, reported differences in functional disability between patients with RA and patients with AS must be interpreted cautiously.
    Clinical and experimental rheumatology 01/2009; 27(4 Suppl 55):S83-91. · 2.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fatigue is a common complaint of patients with primary Sjögren's syndrome (pSS), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA). The aim of this study was to examine and compare in patients with these diseases the course of fatigue within the first hour after awakening and during the day, and to examine sleep disturbance as a potential determinant of fatigue. Eight repeated measurements at 5 fatigue dimensions were assessed on 2 consecutive days in the natural environment of female patients with pSS (n=29), SLE (n=23), RA (n=19), and healthy women (n=52). Sleep disturbance of the previous night was assessed. Fatigue levels and the change of fatigue after awakening and during the day were analysed with analyses of variance (adjusted for age). The patients showed significantly elevated levels at all fatigue dimensions as compared to healthy participants. Fatigue levels decreased in the first hour after awakening in patients with SLE and RA, but increased or did not change in patients with pSS. Fatigue progressively increased during the remainder of the day for all patient groups. Sleep disturbance correlated with overall fatigue levels, but hardly with the change of fatigue within the first hour after awakening. Our study confirms the presence of increased fatigue in patients with pSS, SLE, and RA. Patients with pSS failed to show a decrease in fatigue in the first hour after awakening. Future research should examine the causes of this difference in fatigue after awakening.
    Clinical and experimental rheumatology 01/2010; 28(5):715-21. · 2.72 Impact Factor
Show more


19 Reads
Available from